Halia Therapeutics, Inc., 2026-08-31
A new SEC Form D private-offering notice from Lehi, UT, a $20,000,000 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
Clinical stage biopharmaceutical company developing NLRP3 inflammasome and RAB10 pathway targeted therapies for inflammatory and neurodegenerative diseases including Alzheimer's.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Quantizr, Inc., 2026-09-02, $7.6M, Park City, UT
- Plowshare Therapies LLC, 2026-08-31, $6.7M, Lancaster, PA
- Intelligent Mapping, LLC, 2026-08-31, $4M, Park City, UT
- StrataBio Inc., 2026-08-31, $500K, Tallahassee, FL
- Tavaci Technologies Inc., 2026-08-28, $2.5M, Spanish Fork, UT
- Conexeu Sciences Inc., 2026-08-31, $89K, Reno, NV
- VANTA HOLDINGS INC., 2026-08-31, $51K, Vancouver, BC, Canada
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.